Track market-moving stories before they get noisy

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Strategy (NASDAQ:MSTR | MSTR Price Prediction) has never been a simple way to own Bitcoin (CRYPTO:BTC). Michael Saylor has spent the past several years turning the company into a financial engineering machine, issuing multiple layers of securities to buy even more Bitcoin. Its latest move may be the boldest yet.

The company just unveiled its new Digital Credit Capital Framework, a plan designed to support the growing ecosystem of preferred securities it has created, particularly its STRC preferred shares. The company says the framework will strengthen liquidity, protect dividend payments, and provide additional flexibility during periods of Bitcoin volatility.

But while the announcement appears positive on the surface, investors should recognize that it benefits different shareholders in very different ways. In many respects, the framework offers greater protection for preferred shareholders while increasing the risks borne by common shareholders.

Building a Safety Net The framework introduces several new tools. Strategy established a $2.55 billion cash reserve dedicated to paying preferred dividends and interest. At current obligations, that reserve covers roughly 17 months of payments without requiring additional financing.

The company also raised the dividend on its Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) (commonly called “Stretch”) to 12% annually, effective July 1. The dividend can be adjusted over time in an effort to keep STRC trading close to its $100 par value.

To provide additional flexibility, Strategy authorized two separate $1 billion repurchase programs — one for its digital credit securities, including Stretch, and another for Strategy common shares.

Finally, management authorized up to $1.25 billion of conditional Bitcoin sales if necessary to replenish reserves, meet obligations, or fund buybacks.

Taken together, the framework gives Strategy more options before being forced into emergency financing. But it also highlights just how much of the company’s capital structure now revolves around servicing preferred investors.

From Bitcoin proxy to a high-stakes financial machine—see why common shareholders are now bearing the brunt of the volatility while preferred investors get the shield. © 24/7 Wall St. Why STRC and MSTR Investors Have Different Interests This is where the distinction becomes important. Stretch investors receive a substantial monthly cash dividend while sitting ahead of common shareholders in the capital structure. The new framework is largely designed to improve the likelihood those payments continue regardless of short-term Bitcoin volatility. Common shareholders receive none of those benefits.

Instead, MSTR investors absorb much of the residual risk. If Bitcoin enters another prolonged bear market, Strategy may eventually need to issue additional preferred shares, sell Bitcoin, or issue more common stock to maintain its obligations. Every one of those outcomes can dilute or reduce the value accruing to existing common shareholders.

In effect, Stretch holders are receiving contractual cash income supported by new corporate safeguards. MSTR holders are providing much of that support without receiving a dividend themselves.

That doesn’t mean MSTR can’t outperform if Bitcoin stages another explosive rally. Historically, leverage has amplified gains during bull markets. But the same financial engineering that boosts returns on the way up can become a headwind during prolonged downturns.

The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.

The Risks Haven’t Disappeared The new framework certainly reduces some near-term liquidity concerns, but it doesn’t eliminate the underlying risks.

Strategy currently holds 847,363 Bitcoin purchased for roughly $64.1 billion, representing an average cost of $75,651 per Bitcoin. With Bitcoin recently trading around $61,200, the company’s holdings remain underwater. If Bitcoin remains depressed for an extended period — or falls significantly lower, as some analysts expect — the $2.55 billion reserve eventually runs down.

At that point, Strategy has several options — but none are particularly attractive for common shareholders. It can issue more preferred securities with even higher dividend costs, issue additional common shares that dilute existing investors, or begin selling portions of its Bitcoin holdings.

Ironically, one of the biggest attractions of MSTR has always been Saylor’s promise to accumulate Bitcoin indefinitely. Yet this framework explicitly acknowledges that Bitcoin sales are now part of the financial toolbox if circumstances require them. It’s now a feature, not a bug.

That may reassure preferred investors. It is less soothing for common shareholders.

Key Takeaway The Digital Credit Capital Framework probably makes Stretch a stronger investment by improving the security of its dividend and providing multiple layers of liquidity support. Whether it improves MSTR is a far more complicated question.

Common shareholders now sit beneath an even larger stack of preferred obligations while receiving no income themselves. If Bitcoin performs exceptionally well, MSTR can still deliver outsized gains. But if Bitcoin struggles, common investors bear a disproportionate share of the downside through potential dilution, Bitcoin sales, and growing obligations to preferred shareholders.

For many investors whose primary goal is simply gaining exposure to Bitcoin, buying Bitcoin directly — or through a low-cost spot Bitcoin ETF — may now offer a cleaner investment thesis. Those vehicles provide one-for-one exposure to Bitcoin’s price without the added complexity of leverage, preferred dividends, or corporate financing decisions.

More aggressive investors who believe Saylor’s capital strategy will continue creating value may still prefer MSTR. Income-oriented investors comfortable with crypto-related credit risk may find Stretch attractive.

But the latest framework makes one thing increasingly clear: Strategy is no longer merely a Bitcoin proxy. It has become a highly leveraged financial institution built around Bitcoin, and understanding that distinction is becoming just as important as understanding Bitcoin itself.

If You'd Bought Amazon When the Motley Fool Said To…In September 2002, Stock Advisor told subscribers to buy Amazon. In December 2004, Netflix. In April 2005, Nvidia. The newsletter still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Here's how to get this month's picks:

- Join Stock Advisor for one year, with a 30-day money-back guarantee

- Get this month's two new picks — plus the Top 10 Rankings and the full historical pick list

- Read the analysis, decide for yourself, and trade through your own brokerage

Five years from now, you'll probably wish you'd bought this month's picks. Don't miss them.

Contact [email protected] for any questions or corrections.

NEW YORK--(BUSINESS WIRE)--Regulatory News:

Today, Coty Inc. (NYSE: COTY) (Paris: COTY) announced a set of organizational changes that advance its Coty.Curated strategy by bringing commercial decision-making closer to the center and enabling the company to move faster.

Executive Chairman and interim CEO Markus Strobel will take direct control of Prestige commercial operations, with Coty’s regional leaders reporting to him. The change brings leadership closer to the markets, speeds up decision-making, and sharpens accountability for sell-out and market share.

As part of these changes, Coty will integrate Prestige R&D and sustainability with supply chain into one simplified function under the interim leadership of Graeme Carter, Chief Supply Chain Officer. Bringing prestige innovation, sustainability, and supply chain together under one leader streamlines how the company develops and delivers behind its core businesses. Gordon von Bretten, President of Consumer Beauty, will continue to drive an already integrated model in Consumer Beauty.

Caroline Andreotti, Chief Commercial Officer Prestige, will leave Coty at the end of September after three years in the role and almost two decades with the company. She shaped Coty’s global commercial strategy, its relationships with key customers and partners, and its leadership in prestige.

Dr. Shimei Fan, Chief Scientific and Sustainability Officer, will leave Coty at the end of August. She led the company’s R&D organization and sustainability agenda, helped launch key innovations, and oversaw significant progress including multiple ESG ratings upgrades and the first approval of Coty’s science-based carbon reduction targets by the SBTi.

Markus Strobel, Executive Chairman and interim CEO, said: “Coty.Curated is about clarity and focus, and a simpler operating model helps us deliver on that. It positions us to keep building behind our core brands and to support our teams as the business moves forward. I want to thank Caroline and Shimei for their leadership and their many years of contribution to Coty, and wish them every success for their future endeavors.”

People and Purpose leadership transition

Priya Srinivasan, Chief People and Purpose Officer, has decided to step down for personal reasons and will leave Coty in August. She led the global people function, including leadership development and engagement, and played an important role in advancing Coty’s talent agenda.

Séverine Charbon will join Coty as Chief People and Purpose Officer effective September 1. She brings more than 25 years of international experience in talent strategy and organizational transformation, most recently as Chief Talent Officer International at Publicis Groupe.

Strobel added: “Priya has been a thoughtful and trusted leader, and a real champion of our people and culture. She has strengthened how we develop talent, deepened employee engagement, and helped make Coty a place where people can do their best work. We are grateful for everything she has given to Coty and wish her the very best in the future. We now look forward to Séverine joining Coty at this important time and continuing to build on the strong foundations in place.”

ABOUT COTY INC.

Founded in Paris in 1904, Coty is one of the world’s largest beauty companies, with a portfolio of beloved brands across fragrance, color cosmetics, and skin and body care. Coty serves consumers around the world, selling prestige and mass‑market products in over 120 countries and territories. Together with its brands, Coty empowers people to express the beauty of their individuality – and is committed to transforming the beauty industry to become more sustainable and inclusive through its Beauty That Lasts strategy.

Learn more at coty.com or follow us on LinkedIn and Instagram.

IRVINE, Calif.--(BUSINESS WIRE)--Rivian Automotive, Inc. (NASDAQ: RIVN) today announced production and delivery totals for the quarter ending June 30, 2026. The company produced 12,613 vehicles at its manufacturing facility in Normal, Illinois and delivered 12,194 vehicles during the same period. Delivery results topped Rivian's outlook of 9,000 to 11,000 vehicles for the quarter due to robust growth quarter-over-quarter in EDV and R1 coupled with the introduction of R2 deliveries.

As a result of the progress Rivian has made, and the production and delivery outlook for the second half of the year, the company is today raising its full year 2026 delivery guidance from 62,000 - 67,000 vehicles, to 65,000 - 70,000.

ShareAs a result of the progress Rivian has made, and the production and delivery outlook for the second half of the year, the company is today raising its full year 2026 delivery guidance from 62,000 - 67,000 vehicles, to 65,000 - 70,000.

The company also announced that on July 30, 2026, after market close, it will release its second quarter 2026 financial results. Rivian will host an audio webcast at 5:00 p.m. ET the same day to discuss the performance and outlook for the business. The live webcast will be available at https://rivian-q2-earnings-webcast-2026.open-exchange.net/ and a replay will be available for four weeks at www.rivian.com/investors following the webcast.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our annual delivery outlook.

We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed in Part II, Item 1A, “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, and our other filings with the Securities and Exchange Commission. The forward-looking statements in this press release are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.

About Rivian:

Rivian (NASDAQ: RIVN) is an American automotive technology company that develops and manufactures category-defining electric vehicles as well as vertically integrated technologies and services. Through innovation across its electrical architecture, end-to-end software, autonomous driving platform, artificial intelligence, and propulsion, the company creates vehicles that excel at work and play with the goal of accelerating the global transition to zero-emission transportation and energy. Rivian vehicles are manufactured in the United States and are sold directly to consumer and commercial customers. Whether taking families on new adventures or electrifying fleets at scale, Rivian vehicles all share a common goal — preserving the natural world for generations to come.

SAN DIEGO, July 02, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in the defense, national security and global markets, today announced that it has recently received an approximate $36 million sole-source contract award for a new air defense missile system. Kratos is a recognized industry leader in the rapid engineering, development and production at scale of affordable military-grade hardware, products and systems, including for hypersonic, missile, radar, air defense, directed energy, high-powered microwave, counter unmanned aerial system (C-UAS), chemical, biological, radiological, and nuclear (CBRN), unmanned aerial drone, strategic, and other systems. 

Tom Mills, President of Kratos’ C5ISR Division, said, “Building military-grade hardware on schedule and on budget, hardware that must work every time, is hard, and is also a clear differentiating capability of Kratos. The entire C5ISR team is proud to have been selected for this critical national security program.”

Eric DeMarco, President and CEO of Kratos, said, “Kratos’ air defense related hardware, products, and systems business, both in the United States and internationally, is currently seeing increased demand from numerous customers for multiple systems, platforms and technologies. Over the past several years, Kratos has made significant investments in property, plant, equipment and facilities, which we are continuing as we are laser focused on supporting the United States Department of War and the rebuild and recapitalization of our nation’s defense industrial base.”

Work under this contract award will be performed at a secure Kratos manufacturing facility. Due to security related, competitive and other considerations, no additional information related to this program will be provided.

About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) is a technology, products, system and software company addressing the defense, national security, and commercial markets. Kratos makes true internally funded research, development, capital and other investments, to rapidly develop, produce and field solutions that address our customers’ mission critical needs and requirements. At Kratos, affordability is a technology, and we seek to utilize proven, leading-edge approaches and technology, not unproven bleeding edge approaches or technology, with Kratos’ approach designed to reduce cost, schedule and risk, enabling us to be first to market with cost effective solutions. We believe that Kratos is known as an innovative disruptive change agent in the industry, a company that is an expert in designing products and systems up front for successful rapid, large quantity, low-cost future manufacturing which is a value-add competitive differentiator for our large traditional prime system integrator partners and also to our government and commercial customers. Kratos intends to pursue program and contract opportunities as the prime or lead contractor when we believe that our probability of win (PWin) is high and any investment required by Kratos is within our capital resource comfort level. We intend to partner and team with a large, traditional system integrator when our assessment of PWin is greater or required investment is beyond Kratos’ comfort level. Kratos’ primary business areas include virtualized ground systems for satellites and space vehicles including software for command & control (C2) and telemetry, tracking and control (TT&C), jet powered unmanned aerial drone systems, hypersonic vehicles and rocket systems, propulsion systems for drones, missiles, loitering munitions, supersonic systems, space craft and launch systems, C5ISR and microwave electronic products for missile, radar, missile defense, space, satellite, counter UAS, directed energy, communication and other systems, and virtual & augmented reality training systems for the warfighter. For more information, visit www.KratosDefense.com and follow Kratos on LinkedIn and X.

Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 28, 2025, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.

Press Contact:
Claire Cantrell
[email protected]

Kratos Investor Information:
877-934-4687
[email protected]

CAMBRIDGE, Mass., July 02, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies, Inc. (NASDAQ: AKAM) announces the company has completed its acquisition of secure enterprise browser provider and AI usage control leader LayerX. On May 14, Akamai announced an agreement between the two parties for Akamai to acquire LayerX in exchange for approximately US$205 million.

LayerX offers a browser security platform that allows enterprises to add protections to their preferred, existing browsers. It enables security teams to have greater visibility into how users interact with web content, prompts, file uploads, and SaaS applications both within and outside the browser. The acquisition will build on Akamai’s investment in its Zero Trust platform, which includes market-leading segmentation, Zero Trust Network Access (ZTNA), and DNS security solutions, already trusted by thousands of global customers. By leveraging Akamai’s massive, globally distributed network, the combined solution will create a workforce security solution that addresses a need to govern and secure how employees, partners, and supply chain ecosystems interact with AI applications.

For more information, visit the Akamai Zero Trust solutions page.

About Akamai
Akamai is the cybersecurity and cloud computing company that powers and protects business online. Our market-leading security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. Akamai’s full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. Global enterprises trust Akamai to provide the industry-leading reliability, scale, and expertise they need to grow their business with confidence. Learn more at akamai.com and akamai.com/blog, or follow Akamai Technologies on X and LinkedIn.

Akamai Statement Under the Private Securities Litigation Reform Act
This press release contains statements that are not statements of historical fact and constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about product success and other benefits of the transaction to Akamai. Each of the forward-looking statements is subject to change as a result of various important factors, many of which are beyond Akamai’s control, including, but not limited to: Akamai’s inability to achieve the expected benefits of the transaction; challenges integrating LayerX’s business, employees, and technology; and effects of competition. The forward-looking statements contained herein are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, Akamai disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

Contacts
Johanna Schmitt
Akamai Media Relations
[email protected]

Akamai Investor Relations
[email protected]

TULSA, Okla.--(BUSINESS WIRE)--Alliance Resource Partners, L.P. (NASDAQ: ARLP) ("ARLP") today announced that it has completed its previously announced acquisition of certain general partner and limited partner interests in AllDale Minerals III, LP and AllDale Minerals IV, LP for approximately $206.2 million, subject to customary post-closing adjustments.

ARLP funded the acquisition using a combination of cash on hand, borrowings under its revolving credit facility, and a new $150.0 million term loan at its wholly owned subsidiary Alliance Minerals, LLC.

Following the acquisition, ARLP now controls approximately 115,680 net royalty acres within its Oil & Gas Royalties segment, including over 44,770 net royalty acres in the Permian Basin. ARLP expects to provide additional commentary regarding the acquisition during its next quarterly earnings conference call.

About Alliance Resource Partners, L.P.

ARLP is a diversified natural resource company that is currently the second largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as a reliable energy partner for the future by pursuing opportunities that support the growth and development of energy-related technologies and infrastructure.

News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via email at [email protected].

The statements and projections used throughout this release are based on current expectations. These statements and projections are forward-looking, and actual results may differ materially. These projections do not include the potential impact of any mergers, acquisitions or other business combinations that may occur after the date of this release. We have included more information below regarding business risks that could affect our results.

FORWARD-LOOKING STATEMENTS: With the exception of historical matters, any matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from projected results. Those forward-looking statements include expectations with respect to our future financial and operational performance, coal and oil & gas consumption and expected future prices, our ability to increase or maintain unitholder distributions in future quarters, business plans and potential growth with respect to our energy and infrastructure investments, optimizing cash flows, reducing operating and capital expenditures, infrastructure projects at our existing properties, growth in domestic electricity demand, preserving liquidity and maintaining financial flexibility, and our future repurchases of units. These risks to our ability to achieve these outcomes include, but are not limited to, the following: decline in the coal industry’s share of electricity generation, including as a result of environmental concerns related to coal mining and combustion, the cost and perceived benefits of other sources of electricity and fuels, such as oil & gas, nuclear energy, and renewable fuels and the retirement of coal-fired power plants in the U.S.; our ability to provide fuel for growth in domestic energy demand, should it materialize; changes in macroeconomic and market conditions and market volatility, and the impact of such changes and volatility on our financial position; changes in global economic and geo-political conditions or changes in industries in which our customers operate; changes in commodity prices, demand and availability which could affect our operating results and cash flows; impacts of geopolitical events, including the conflicts in Ukraine and in the Middle East; actions of the major oil-producing countries with respect to oil production volumes and prices and the direct and indirect impacts over the near and long term on oil & gas exploration and production operations at the properties in which we hold mineral interests; changes in competition in domestic and international coal markets and our ability to respond to such changes; potential shut-ins of production by the operators of the properties in which we hold oil & gas mineral interests due to low commodity prices or the lack of downstream demand or storage capacity; risks associated with the expansion of and investments into the infrastructure of our operations and properties, including the timing of such investments coming online; our ability to identify and complete acquisitions and to successfully integrate such acquisitions into our business and achieve the anticipated benefits therefrom; our ability to identify and invest in new energy and infrastructure ventures; the success of our development and growth plans for our wholly owned subsidiary, Matrix Design Group, LLC, and our investments in emerging and other infrastructure and technology companies; dependence on significant customer contracts, and failure of customers to renew existing contracts upon expiration; adjustments made in price, volume, or terms to existing coal supply agreements; the effects of and changes in trade, monetary and fiscal policies and laws, and the results of central bank policy actions including interest rates, bank failures, and associated liquidity risks; the effects of and changes in taxes or tariffs and other trade measures adopted or threatened by the United States and foreign governments, including the imposition of or increase in tariffs on steel and/or other raw materials; legislation, regulations, and court decisions and interpretations thereof, both domestic and foreign, including those relating to the environment and the release of greenhouse gases, such as state legislation seeking to impose liability on a wide range of energy companies under greenhouse gas “superfund” laws, mining, miner health and safety, hydraulic fracturing, and health care; deregulation of the electric utility industry or the effects of any adverse change in the coal industry, electric utility industry, or general economic conditions; investors’ and other stakeholders’ attention to sustainability matters; liquidity constraints, including those resulting from any future unavailability of financing; customer bankruptcies, cancellations or breaches to existing contracts, or other failures to perform; customer delays, failure to take coal under contracts or defaults in making payments; our productivity levels and margins earned on our coal sales; disruptions to oil & gas exploration and production operations at the properties in which we hold mineral interests; changes in equipment, raw material, service or labor costs or availability, including due to inflationary pressures or tariffs; changes in our ability to recruit, hire and maintain labor; our ability to maintain satisfactory relations with our employees; increases in labor costs, including increases in the costs of health insurance, adverse changes in work rules, or cash payments or projections associated with workers’ compensation claims; increases in transportation costs and risk of transportation delays or interruptions; operational interruptions due to geologic, permitting, labor, weather, supply chain shortage of equipment or mine supplies, or other factors; risks associated with major mine-related accidents, mine fires, mine floods or other interruptions; results of litigation, including claims not yet asserted; foreign currency fluctuations that could adversely affect the competitiveness of our coal abroad; difficulty maintaining our surety bonds for mine reclamation as well as workers’ compensation and black lung benefits; difficulty in making accurate assumptions and projections regarding post-mine reclamation as well as pension, black lung benefits, and other post-retirement benefit liabilities; uncertainties in estimating and replacing our coal mineral reserves and resources; uncertainties in estimating and replacing our oil & gas reserves; uncertainties in the amount of oil & gas production due to the level of drilling and completion activity by the operators of our oil & gas properties; the impact of current and potential changes to federal or state tax rules and regulations, including a loss or reduction of benefits from certain tax deductions and credits; difficulty obtaining commercial property insurance, and risks associated with our participation in the commercial insurance property program; evolving cybersecurity risks, such as those involving unauthorized access, denial-of-service attacks, malicious software, data privacy breaches by employees, insiders or others with authorized access, cyber or phishing attacks, ransomware, malware, social engineering, physical breaches, or other actions; and difficulty in making accurate assumptions and projections regarding future revenues and costs associated with equity investments in companies we do not control.

Additional information concerning these, and other factors can be found in ARLP’s public periodic filings with the SEC, including ARLP’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 26, 2026, and ARLP’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed on May 8, 2026. Except as required by applicable securities laws, ARLP does not intend to update its forward-looking statements.

More News From Alliance Resource Partners, L.P.

Bloom Energy (BE 4.51%) is perfectly positioned for the artificial intelligence spending boom underway today. In fact, the company's backlog for hydrogen fuel cells at the start of 2026 rose over 2.5x year over year, hitting $6 billion. But the real story here is the other $14 billion of the total $20 billion backlog, which is related to services.

What does Bloom Energy do? Bloom Energy makes hydrogen fuel cells. They are built in a factory and can be delivered wherever they are needed to provide on-site power. The power generated doesn't produce greenhouse gases, either, so it is clean energy. The company has been building its business and improving its technology for many years, but the current environment is almost the perfect setting for success.

Image source: Getty Images.

Spending on artificial intelligence (AI) has exploded. But AI is just a fancy computer program, so it can't operate without electricity. Electric utilities are working to supply the power needed, but building electric infrastructure takes time. And there has been pushback from consumers and regulators around the impact that AI demand is having on power prices.

Bloom Energy's on-site power lets AI companies sidestep the grid. And Bloom Energy can usually deliver power cells more quickly than a utility can provide a grid connection, speeding up the construction of new AI data centers. No wonder the company started 2026 with a $6 billion backlog of fuel cell orders, up 2.5x year over year.

Bloom Energy's real flywheel is services That said, the company's full backlog is around $20 billion. The other $14 billion relates to the service contracts that accompany the sale of a fuel cell. These are long-term contracts that provide annuity-like income streams. Each new product sale builds the company's long-term service momentum. Although Bloom Energy is really just a start-up that has yet to turn sustainably profitable, that could change very soon.

Today's Change

(

-4.51

%) $

-13.65

Current Price

$

289.05

The only problem with Bloom Energy's story is that it is so well-known on Wall Street. The stock is up over 1,000% over the past year. Without sustainable earnings, the price-to-earnings ratio isn't meaningful. However, the price-to-sales ratio is shockingly high at 29x, compared to a five-year average of 3.1x. The forward P/E ratio is 134x. That is high and shows just how much investors are expecting from the company.

Bloom Energy is probably best left on your wishlist for now, given the stock's rapid ascent. However, if the AI bubble on Wall Street bursts, Bloom Energy's massive service backlog could make it worth a second look.

, /PRNewswire/ -- Hagerty, Inc. (NYSE: HGTY), a business that makes it easier and more enjoyable to be a driving enthusiast through insurance, buying and selling platforms, publishing and events, today announced that it has entered into a definitive agreement to acquire Bennetts, the United Kingdom's #2 specialty motorcycle insurance broker, from Lucida Group for £34 million ($43 million USD). The transaction is expected to be immediately accretive, and close during the third quarter of 2026, subject to regulatory approval. The acquisition increases Hagerty's international scale, augmenting the ongoing investment into Hagerty's Broad Arrow business outside of the United States.

Hagerty Agrees to Acquire Bennetts to Become #2 Specialty Motorcycle Insurance Broker in the United Kingdom Founded more than 90 years ago, Bennetts brings 15% UK motorcycle insurance market share and a 65 Net Promoter Score through a member-centric approach similar to Hagerty's model in the enthusiast car space.

"Bennetts is a brand built the same way Hagerty was built – by genuine enthusiasts, for genuine enthusiasts," said McKeel Hagerty, Chief Executive Officer and Chairman of Hagerty. "Their 100,000 community members from Bennetts' 'Bike Social' platform, decades of trust in the UK motorcycle market and disciplined, low-frequency book make this a natural extension of everything we stand for as we look to seed our international growth in a deliberate way."

Mark Roper, Hagerty's UK Managing Director added, "We are excited to welcome the Bennetts team into the Hagerty family. Bennetts has built something special — a brand riders trust, a community they love and a business with momentum. Our commitment is simple: keep what makes Bennetts great, and bring the best of Hagerty alongside it, building something stronger than either of us could on our own."

Tripling Hagerty's UK Footprint
The acquisition is also expected to triple Hagerty's UK revenue to approximately £25 million, and to be financially accretive from day one, even before the realisation of identified synergies.

This acquisition builds on the international momentum Hagerty has established through Broad Arrow Auctions, which has expanded its European presence over the past year. Together, both brands can create a more integrated enthusiast platform in the United Kingdom – combining specialty insurance, live and digital auctions and community engagement across both motorcycles and enthusiast cars with meaningful cross-sell opportunities.

Bennetts' book comprises 92% enthusiast riders and has a risk profile that closely mirrors Hagerty's enthusiast car insurance portfolio. Bennetts' 4.7/5.0 Trustpilot rating, 250,000 YouTube subscribers, and 41 million annual social media interactions reflects an exceptional level of authentic community engagement.

Editors Notes.

About Bennetts

Established in 1930, Bennetts is one of the UK's leading motorcycle insurance brokers, offering Defaqto 5 Star Rated coverage across classic and modern bikes. With a panel of trusted insurers and a comprehensive suite of policy features, Bennetts combines competitive pricing with an exceptional customer experience. Riders who insure directly with Bennetts receive free BikeSocial membership, an exclusive platform offering discounts, experiences, and a thriving enthusiast community.

About Hagerty, Inc. (NYSE: HGTY)
Hagerty is a company built by drivers for drivers, protecting 2.9 million vehicles in the United States, Canada and the UK. We make it easier and more enjoyable for enthusiasts to drive and celebrate the machines they love through innovative insurance products, live and digital auctions, engaging media and events, as well as the Hagerty Drivers Club, the world's largest community of car lovers.

Forward-Looking Statements - All statements contained in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected timing and completion of the acquisition and its anticipated strategic, operational and financial impact. Forward-looking statements are based on Hagerty's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including the risk (i) that the acquisition may not be completed on the expected terms or timeline, or at all; (ii) that the closing conditions may not be satisfied; (iii) that the anticipated benefits of the acquisition may not be realized, including earnings enhancements and synergies; (iv) that Hagerty may be unable to successfully integrate Bennetts with its U.K. business or that integration costs may exceed expectations; (v) of potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement of the acquisition; (vi) that Hagerty may not have identified certain risks relating to Bennetts' business or underestimated the severity or probability of certain risks relating to Bennetts' business; and (vii) other risks described in Hagerty's filings with the U.S. Securities and Exchange Commission. Hagerty undertakes no obligation to update or revise any forward-looking statements, except as required by law.

SOURCE Hagerty

REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced results from two Phase 1/2 clinical trials evaluating zoldonrasib, its oral RAS(ON) G12D-selective covalent inhibitor, in combination regimens for patients with RAS G12D metastatic pancreatic ductal adenocarcinoma (PDAC). The results, which will be presented today in a proffered paper session at the 2026 European Society for Medical Oncology (ESMO) Gastrointestinal Cancers Congress, include zoldonrasib in combination with standard of care chemotherapy in previously untreated patients and zoldonrasib in combination with daraxonrasib, the company’s oral RAS(ON) multi-selective inhibitor, in previously treated patients.

“The Phase 3 RASolute 302 results provided clinical validation of RAS(ON) inhibition with daraxonrasib in second line metastatic pancreatic cancer and established a strong foundation for evaluating this therapeutic approach across additional RAS genotypes, treatment settings and combination strategies. The results presented at ESMO GI demonstrate compelling proof-of-concept for two zoldonrasib-based regimens in RAS G12D disease: combination with standard of care chemotherapy in previously untreated patients and a RAS(ON) inhibitor doublet with daraxonrasib in previously treated patients. Together, these findings are the foundation of two distinct Phase 3 strategies we are pursuing in previously untreated metastatic RAS G12D pancreatic cancer: the ongoing RASolute 305 trial evaluating zoldonrasib plus standard of care chemotherapy, and the planned RASolute 309 trial evaluating the combination of zoldonrasib plus daraxonrasib,” said Alan Sandler, M.D., chief development officer of Revolution Medicines.

Safety and Efficacy of Zoldonrasib Plus Chemotherapy in Patients with First Line RAS G12D Metastatic Pancreatic Cancer (Abstract #340O)

RMC-GI-102 (NCT06445062) is an ongoing Phase 1/2 trial evaluating zoldonrasib 1200 mg once daily in combination with investigator's choice of standard of care chemotherapy in patients with previously untreated metastatic RAS G12D PDAC. Investigator's choice of chemotherapy includes modified FOLFIRINOX (mFFX) or gemcitabine plus nab-paclitaxel (GnP). As of the February 8, 2026 data cutoff, the trial enrolled 41 patients in the zoldonrasib plus mFFX arm and 40 patients in the zoldonrasib plus GnP arm.

Zoldonrasib demonstrated a manageable safety and tolerability profile in combination with standard chemotherapy. The safety profile of zoldonrasib in combination with chemotherapy was broadly consistent with the established profiles of each respective chemotherapy regimen. Grade 3 or greater treatment-related adverse events (TRAEs) occurred in 61% of patients who received the zoldonrasib plus mFFX and 80% of patients who received zoldonrasib plus GnP. The most common Grade 3 or greater TRAEs with zoldonrasib plus mFFX were decreased neutrophil count (37%), anemia (12%), and platelet count decreased (7%). The most common Grade 3 or greater TRAEs with zoldonrasib plus GnP were decreased neutrophil count (35%), anemia (28%), and fatigue (25%). No Grade 5 TRAEs were reported in either arm. The mean dose intensity was 86% with zoldonrasib plus mFFX and 90% with the zoldonrasib plus GnP.

In the trial, zoldonrasib with chemotherapy showed compelling antitumor activity, with an objective response rate (ORR) of 82% (95% confidence interval [CI]: 60, 95) and disease control rate (DCR) of 96% (95% CI: 77, 100) in the mFFX population, and an ORR of 61% (95% CI: 42, 78) and DCR of 90% (95% CI: 74, 98) in the GnP population.

These preliminary safety and clinical activity data support the ongoing RASolute 305 pivotal trial (NCT07621718), a global, randomized, double-blind placebo-controlled Phase 3 clinical trial evaluating zoldonrasib plus investigator’s choice of standard of care chemotherapy compared with placebo plus investigator’s choice of chemotherapy in patients with previously untreated metastatic RAS G12D PDAC.

Safety and Efficacy of Zoldonrasib Plus Daraxonrasib in Patients with Second Line-Plus RAS G12D Metastatic Pancreatic Cancer (Abstract #341O)

RMC-9805-001 (NCT06040541) is a Phase 1 trial evaluating zoldonrasib 1200 mg once daily plus daraxonrasib 300 mg once daily in advanced solid tumors with RAS G12D mutations. As of the February 9, 2026 data cutoff, 60 patients with RAS G12D metastatic PDAC who had previously received one or more prior lines of therapy were treated with the combination.

Zoldonrasib plus daraxonrasib demonstrated a manageable safety and tolerability profile that was broadly consistent with the established profile of daraxonrasib monotherapy. Grade 3 or greater TRAEs occurred in 35% of patients who received the combination. Among TRAEs occurring in 10% or more of all patients, the most common Grade 3 or greater events were rash (12%), anemia (10%), and stomatitis/mucositis (7%). Few patients discontinued due to TRAES; 2% discontinued zoldonrasib and 5% discontinued daraxonrasib. The mean dose intensity was 88% for zoldonrasib and 76% for daraxonrasib.

The zoldonrasib plus daraxonrasib combination demonstrated compelling antitumor activity in patients with previously treated metastatic PDAC. In the second line cohort (2L) (N=30), the ORR was 50% (95% CI: 31–69) and DCR was 97% (95% CI: 83–100). Median progression-free survival (PFS) in the 2L cohort was 9.6 months (95% CI: 7.1–NE), with a 6-month PFS rate of 71%. Median overall survival (OS) in the 2L cohort was not yet estimable, with a 6-month OS rate of 89%. In the third line and beyond (3L+) cohort (N=30), the ORR was 47% (95% CI: 28–66) and DCR was 90% (95% CI: 74–98). Median PFS in the 3L+ cohort was 7.6 months (95% CI: 4.6–10.5), with a 6-month PFS rate of 59%. Median OS in the 3L+ cohort was 10.5 months (95% CI: 6.7–NE), with a 6-month OS rate of 82%.

These safety and clinical activity data support the planned pivotal global, Phase 3 RASolute 309 clinical trial of zoldonrasib plus daraxonrasib versus GnP in patients with previously untreated RAS G12D metastatic PDAC.

About Pancreatic Cancer and Pancreatic Ductal Adenocarcinoma
Pancreatic cancer is one of the most lethal malignancies, characterized by its typically late-stage diagnosis, resistance to standard chemotherapy, and high mortality rate. Pancreatic ductal adenocarcinoma, or PDAC, is the most common form of pancreatic cancer. Due to the lack of early symptoms and effective detection methods, approximately 80% of patients are diagnosed with advanced or metastatic disease. PDAC is the most commonly RAS-driven malignancy of all major cancers, with more than 90% of patients having tumors that harbor RAS mutations.1 RAS G12D is the most prevalent RAS mutation subtype in PDAC, occurring in 40% of patients, and has been associated with poorer outcomes than RAS wild-type disease and certain other RAS-mutant subgroups.1-4

About Zoldonrasib
Zoldonrasib is an investigational, oral RAS(ON) G12D-selective covalent tri-complex inhibitor. RAS G12D is the most prevalent RAS mutation, accounting for 29% of all RAS cancers.1 Across tumor types, approximately 61,000 new patients with RAS G12D cancers are estimated each year in the U.S., and no targeted therapy is currently approved for these patients.5 Zoldonrasib is currently being evaluated as a monotherapy and in combination with other therapies, including with Revolution Medicines’ RAS(ON) multi-selective inhibitor daraxonrasib (RMC-6236), as well as standard of care regimens in lung and gastrointestinal cancers.

About Daraxonrasib
Daraxonrasib is an investigational, oral RAS(ON) multi-selective, non-covalent tri-complex inhibitor. The U.S. Food and Drug Administration (FDA) granted daraxonrasib Breakthrough Therapy Designation and Orphan Drug Designation for the treatment of patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) harboring G12 mutations. In addition, daraxonrasib was selected for the FDA Commissioner’s National Priority Voucher pilot program, which is intended to accelerate the development and review of therapies aligned with U.S. national health priorities.

Daraxonrasib is designed to target cancers driven by a broad range of common RAS genotypes, including PDAC, non-small cell lung cancer (NSCLC), and colorectal cancer. Daraxonrasib is being advanced through a global Phase 3 registrational program comprising four trials, including the completed RASolute 302 trial and three additional trials in patients with PDAC and metastatic RAS mutant NSCLC.

About Revolution Medicines, Inc.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Additional development opportunities in the company’s pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit www.revmed.com and follow us on LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered “forward-looking statements,” including without limitation statements regarding our development strategy, including in RAS G12D pancreatic cancer; the potential of our product candidates for RAS(ON) inhibition, including in pancreatic cancer; the ability of daraxonrasib or zoldonrasib to improve patient outcomes; planned and ongoing clinical studies; and potential efficacy of the company’s product candidates being studied.

Forward-looking statements are typically, but not always, identified by the use of words such as “anticipate,” "estimate," "plan," “potential,” “proof-of-concept,” “pursuing,” "will" and other similar terminology indicating future results. Such forward-looking statements are subject to substantial risks and uncertainties that could cause the company’s development programs, future results, performance, or achievements to differ materially from those anticipated in the forward-looking statements. Such risks and uncertainties include without limitation risks and uncertainties inherent in the drug development process, including the company’s programs’ development stages, the process of designing and conducting preclinical and clinical trials, the regulatory approval processes, the timing of regulatory filings, the challenges associated with manufacturing drug products, the company’s ability to successfully establish, protect and defend its intellectual property, other matters that could affect the sufficiency of the company’s capital resources to fund operations, reliance on third parties for manufacturing and development efforts, changes in the competitive landscape, and the effects on the company’s business of the global events, such as international conflicts or global pandemics. For a further description of the risks and uncertainties that could cause actual results to differ from those anticipated in these forward-looking statements, as well as risks relating to the business of Revolution Medicines in general, see Revolution Medicines’ Annual Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on May 6, 2026, and its future periodic reports to be filed with the SEC. Except as required by law, Revolution Medicines undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances, or to reflect the occurrence of unanticipated events.

Revolution Medicines Media & Investor Contact:
[email protected]
[email protected]

References

1 Lee JK, Sivakumar S, Schrock AB, et al. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors. NPJ Precis Oncol. 2022;6(1);91. doi:10.1038/s41698-022-00334-z
2 Yousef, A., Yousef, M., Chowdhury, S. et al. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. NPJ Precis Oncol. 2024;8:27. https://doi.org/10.1038/s41698-024-00505-0
3 Qian ZR, Rubinson DA, Nowak JA, et al. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2018;4(3):e173420. doi:10.1001/jamaoncol.2017.3420
4 Norton C, Shaw MS, Rubnitz Z, et al. KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. JAMA Netw Open. 2025;8(1):e2453588. doi:10.1001/jamanetworkopen.2024.53588
5 Estimated using tumor mutation frequencies from Foundation Medicine Insights March 2022 and scaled to estimated patient numbers using cancer incidence from ACS Cancer Facts and Figures 2023.

The milestone marks the expansion of Ondo – the leader in tokenized securities by total value – into the U.S. For the first time, U.S. listed securities – BlackRock's iShares Core S&P 500 (IVV) ETF and Micron (MU) shares – were tokenized by a third party on a public blockchain while staying within the existing U.S. regulatory and infrastructure framework Broadridge will enable holders of the tokenized securities to participate in proxy voting and receive regulatory disclosures, seamlessly providing token holders with the same protections and rights as holders of traditional securities Investors in securities tokenized by Ondo will have a common voting and shareholder communications platform and experience for synthetic and custodial tokenized securities leveraging Broadridge's ProxyVote.com platform , /PRNewswire/ -- Ondo Finance today announced the first live solution of third-party tokenized U.S. securities operating entirely within the existing regulatory perimeter in the U.S., in partnership with Broadridge Financial Solutions Inc., (NYSE: BR) to provide full voting rights for tokenized equity holders.

In its January 2026 statement on tokenized securities, the SEC described a custodial model in which a third party holds an issuer's securities and issues crypto assets representing a holder's entitlement to the underlying security. Ondo's launch of tokenized BlackRock iShares Core S&P 500 (IVV) ETF and Micron (MU) stock are the first production deployments of that model in the U.S.

Under this model, which closely follows the SEC's third-party custodial model, the underlying shares never leave the traditional U.S. regulated custody chain. Ondo's registered transfer agent mints corresponding tokens, backed 1:1 by those shares, which are issued on the Ethereum blockchain and held by regulated custodians. Each token holder will receive the same shareholder rights and protections as shareholders holding through U.S. brokerage accounts receive, including issuer communications and onchain proxy voting through Broadridge's ProxyVote.com platform.  Transfer restrictions are enforced by the participating broker-dealer, transfer agent, and custodian in accordance with existing regulatory requirements and practices, maintaining full regulatory compliance.

"Tokenized Securities in the U.S. are too often framed as a binary choice between competing models and tokenization providers. This is a false premise. Ondo has built the regulatory, product, and service infrastructure to support all major models within the United States. Today's milestone shows we can tokenize securities in ways that meet both market and regulatory requirements, for U.S. and global investors and provides a strong foundation for our expanding access to onchain investments for more U.S. investors," said Ian De Bode, CEO of Ondo Finance.

Today's announcement marks a major step forward for tokenized securities in the United States. Until now, tokenized securities have largely operated outside the U.S. or have required issuer sponsorship on an issuer-by-issuer basis. This model brings them inside the U.S. regulatory perimeter, with the underlying securities held in the same infrastructure that custodies U.S. securities today. This new structure shows how the benefits of tokenization can be attained while preserving the safeguards, recordkeeping, and market infrastructure that underpin U.S. capital markets.

"Tokenization will only scale when it delivers both innovation and investor confidence," said Doug DeSchutter, President of Broadridge's Investor Communication Solutions business. "By enabling proxy voting, issuer communications, and regulatory disclosures for Ondo's token holders, we're living up to our promise to empower investors and issuers by providing them with the full range of trusted governance capabilities for tokenized securities regardless of how assets are structured."

The launch is another milestone in realizing Broadridge's strategy to enable the adoption of tokenized securities by ensuring that they are supported by governance capabilities with the highest standards for auditability, accountability, and investor protection and comply with U.S. regulatory guidelines. Broadridge supports all models of tokenized securities, including issuer-listed models, synthetic tokenized securities issued outside the United States, and now, third-party tokenized shares within the U.S. by ensuring that investors get the critical communications they need to exercise their voting rights and stay informed about their investments.

About Ondo Finance

Ondo Finance is a blockchain-based technology company focused on tokenizing real-world assets and bringing institutional-quality financial products onchain. By bridging traditional finance and decentralized infrastructure, Ondo aims to make capital markets more accessible, transparent, and efficient.

The Global Markets platform for Ondo tokenized securities outside of the U.S. currently supports more than $1 billion in tokenized securities across 430+ tokenized stocks & ETFs. This launch expands Ondo's tokenization footprint into the U.S., to enable third-party issuance of tokenized security entitlements for major ETFs and stocks.

Oasis Pro TA, LLC, an SEC-registered transfer agent and indirect wholly owned subsidiary of Ondo Finance Inc., issues the tokenized security entitlements in the new model herein described. Such tokenization services are not a regulated activity of Oasis Pro TA, LLC.

About Broadridge's Tokenization Solutions

Broadridge enables onchain proxy voting and governance, digital asset infrastructure including post-trade, wallets and custody, and the scaling of digital asset capabilities across multiple asset classes. Through these innovations, Broadridge is helping financial institutions unlock the next era of digital asset investing.

Broadridge's Distributed Ledger Repo solution is the world's largest institutional platform for settling tokenized real assets. As tokenization gains momentum across financial services, Broadridge is meeting the complexity of operating across traditional and digital ecosystems with established scale, critical market knowledge, and technological expertise.

About Broadridge

Broadridge Financial Solutions (NYSE: BR) is a global technology leader with trusted expertise and transformative technology, helping clients and the financial services industry operate, innovate, and grow. We power investing, governance, and communications for our clients – driving operational resiliency, elevating business performance, and transforming investor experiences.

Our technology and operations platforms process and generate over 7 billion communications annually and underpin the daily average trading of over $15 trillion in tokenized and traditional securities globally. A certified Great Place to Work®, Broadridge is part of the S&P 500® Index, employing over 15,000 associates in 21 countries.

For more information about us, please visit www.broadridge.com

SOURCE Ondo Finance

Banners displaying the NATO logo are placed at the entrance of new NATO headquarters during the move to the new building, in Brussels, Belgium April 19, 2018. REUTERS/Yves Herman Purchase Licensing Rights, opens new tab

BERLIN/PARIS, July 2 (Reuters) - NATO will announce plans ​at next week's ‌Ankara summit to replace its ageing ​fleet of ​AWACS aircraft with GlobalEye ⁠surveillance planes ​from Sweden's Saab (SAABb.ST), opens new tab, four ​sources familiar with the matter said.

NATO, whose ​members are ​due to meet in the ‌Turkish ⁠capital on July 7 and 8, did not ​immediately ​respond ⁠to a request for comment. ​Saab declined ​to ⁠comment.

The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.

Reporting by Sabine Siebold and ⁠Tim ​Hepher, Additional ​reporting by Simon Johnson; editing ​by Barbara Lewis

Our Standards: The Thomson Reuters Trust Principles., opens new tab

, /PRNewswire/ - GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) ("GFL" or the "Company") today announced that the Board of Directors of the Company has declared a cash dividend of US$0.0169 for each outstanding subordinate voting share and multiple voting share of the Company for the second quarter of 2026.

The cash dividend will be paid on July 31, 2026 to shareholders of record at the close of business on July 13, 2026. The Company has designated this dividend as an eligible dividend within the meaning of the Income Tax Act (Canada).

About GFL

GFL is the fourth largest diversified environmental services company in North America, providing comprehensive solid waste management services from its platform of facilities throughout Canada and 18 U.S. states. GFL has a workforce of more than 15,000 employees across its organization.

Forward Looking Statements

This release includes certain "forward-looking statements", which are not guarantees or assurances of future performance. Because forward-looking statements are related to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. GFL undertakes no obligation to publicly update any forward-looking statement, except as required by applicable securities laws. The declaration, timing, amount and payment of any future dividends remains at the discretion of GFL's Board of Directors.  

For more information:
Patrick Dovigi
+1 905-326-0101
[email protected]

SOURCE GFL Environmental Inc.

Chipmaker Nvidia says it is entering revenue-sharing agreements with fast-growing start-ups, in a move which will see customers swap access to compute power for a slice of future profits.

The artificial intelligence chip leader says its new partnership program, announced Thursday, offers fast-growing AI startups token credits to power their development. Cloud-based AI firms, model builders and other enterprises will share both product and cloud revenue with Nvidia, which is positioning itself as an intermediary helping startups gain direct access to full-stack computing powered by Nvidia chips.

In its announcement, Nvidia named two initial partners who will provide the compute power behind the scheme. Australia-based Sharon AI will deploy up to 40,000 Nvidia GPUs, while Singapore AI infrastructure company Firmus Technologies says it is building a data center in Batam, Indonesia, which is expected to scale to 360 megawatts and house up to 170,000 Nvidia GPUs.

Nvidia's move illustrates the critical importance of access to scarce compute power for AI-oriented startups, with GPUs likened to oil and even reportedly tied to futures contracts as users grapple with fluctuations in cost and issues around availability. Meanwhile, AI firms have increasingly entered into revenue and equity-sharing sharing agreements with chipmakers in order to circumvent liquidity issues afflicting the sector.

OpenAI has inked a number of deals that have seen it buy shares or entertain investments from partners including Amazon and AMD, CNBC reported in January.

Nvidia earlier this month said it was aiming to raise debt which sources said could amount to at least $20 billion. The firm intends to use the proceeds from the offering for general corporate purposes, including repayment and refinancing of existing debt.

Artificial intelligence (AI) has become more than a technology initiative at UnitedHealth Group (UNH +2.63%). It's increasingly becoming a business strategy.

The company plans to invest $3 billion in AI across 2026 and 2027, and management says it's already generating roughly $2 of value for every $1 invested through lower administrative costs, higher productivity, and new software products.

That's not a trivial development from one of the largest healthcare companies in the world.

Image source: Getty Images.

AI is tackling healthcare's biggest inefficiencies Healthcare remains one of the most administratively complex industries in the United States.

Insurance claims, prior authorizations, billing, scheduling, customer service, and medical documentation require enormous amounts of manual work. In fact, data from Morgan Stanley show that insurers and healthcare providers collectively spend roughly $80 billion each year on administrative transactions.

About one-third of the company's AI investment is going toward software products within Optum Insight (the company's technology and data analytics division). At the same time, the remaining two-thirds is focused on improving internal operations. The objective isn't simply to make employees more productive. It's to redesign workflows across the organization.

The returns are already showing up Unlike some corporate AI initiatives that remain largely experimental, UnitedHealth says it's already seeing measurable benefits.

AI tools are helping automate customer service, summarize clinical records, detect fraud, schedule appointments, and process administrative requests that previously required significant human involvement. As a result, management expects much of the return on its AI investments to materialize within 12 to 18 months.

The company is also using AI to improve prior authorization. Today, approximately 95% of prior authorization requests are submitted electronically, about half are processed in real time, and 90% receive a decision within one business day.

For a company serving nearly 150 million people, even small efficiency improvements can produce meaningful financial results.

This is not a random trend UnitedHealth isn't investing in AI simply to keep up with the latest technology trend. The company is trying to solve one of healthcare's biggest cost problems.

If AI continues reducing administrative expenses while improving customer service and speeding up care decisions, it could expand margins across multiple business lines. At the same time, Optum Insight plans to commercialize many of the AI tools it develops internally, creating another potential source of recurring revenue.

The broader business also continues to perform well.

In the first quarter of 2026, UnitedHealth generated $111.7 billion in revenue and adjusted earnings of $7.23 per share, both ahead of Wall Street expectations. Management also raised full-year earnings guidance to more than $18.25 per share, reflecting improving operating performance.

Today's Change

(

2.63

%) $

10.91

Current Price

$

426.54

Lowering costs and improving productivity Artificial intelligence won't solve every challenge facing UnitedHealth. Healthcare remains heavily regulated, reimbursement rates continue to evolve, and medical costs remain difficult to predict.

But unlike many companies still searching for practical AI applications, UnitedHealth is deploying the technology where it can directly lower costs and improve productivity. If management continues delivering the returns it's projecting, AI could become a meaningful driver of long-term earnings growth.

And that's what makes this initiative worth watching.

AI isn't just another expense for UnitedHealth. It has the potential to become a significant competitive advantage.

Key Takeaways General Mills says fiscal 2027 will focus on innovation, renovation and sharper brand execution.General Mills targets $3B in cumulative cost savings through fiscal 2030 to fund reinvestment.General Mills expects organic sales from down 1.5% to up 0.5% and adjusted EPS of $3.00-$3.20. General Mills, Inc. (GIS - Free Report) used its fourth-quarter call to argue that fiscal 2026 was a reset year, not an endpoint. Management said pricing work is largely complete, and fiscal 2027 will shift toward innovation, renovation and sharper brand execution.

That message came with a more aggressive productivity plan. Executives paired a modest organic sales outlook with a new $3 billion cumulative cost-savings target through fiscal 2030, framing efficiency as the funding source for both growth investment and margin protection.

GIS Shifts From Pricing to InnovationChairman and CEO Jeffrey Harmening said the company entered fiscal 2026 focused on restoring competitiveness through base pricing. On the call, he described that work as largely finished and said the next step is to make the rest of General Mills’ marketing and product activity work harder.

Harmening tied the fiscal 2027 playbook to product benefits consumers are willing to pay for, including protein, fiber, bold flavors and indulgence. He cited Cheerios, Blue Buffalo, Häagen-Dazs and Annie’s as brands where the company sees room to improve remarkability and mix.

The shift matters because management is not counting on a better consumer backdrop to do the heavy lifting. Executives repeatedly said growth improvement should come from company-controlled levers rather than a rebound in categories.

General Mills Sees a Tough Consumer Holding OnDana McNabb, COO and group president of North America Retail and North America Pet, said the company expects shoppers to remain pressured in fiscal 2027. She said consumers are buying more on promotion, making channel and pack-size tradeoffs, and keeping value at the center of purchase decisions.

McNabb added that categories slowed by about one point exiting the fourth quarter, and management is not assuming that trend reverses soon. Instead, the company is trying to pair better shelf pricing with premium benefits that can still command spending.

That backdrop helps explain the company’s fiscal 2027 guidance. General Mills expects organic net sales to range from down 1.5% to up 0.5%, with adjusted operating profit down 13% to down 8% in constant currency and adjusted EPS of $3.00 to $3.20.

GIS Keeps Totino’s and Pet in FocusAnalyst questions repeatedly returned to market share, and management did not dodge the weak spots. Harmening said Totino’s was a bigger issue than Wilderness dog feeding because of its size, while McNabb said Totino’s suffered from poor execution on price-pack architecture and insufficient innovation.

Management pointed to early fixes, including stronger merchandising, new frozen snack launches and better product architecture. McNabb said June trends had already improved in hot snacks and pizza, though she stopped short of calling four weeks a durable trend.

In Pet, the issue was less consumption than inventory flow. McNabb said channel sales were up 1% for the year, but organic sales lagged because faster-growing customers such as e-commerce and mass carry less inventory, and she said a low-single-digit inventory headwind is built into fiscal 2027 assumptions.

General Mills Pairs Savings With ReinvestmentThe biggest new strategic number from the call was the $3 billion cost-savings target through fiscal 2030. About $2 billion is expected from Holistic Margin Management, while the remaining $1 billion is tied to transformation and other efficiency work.

McNabb said the supply chain is a particular focus, arguing it was built for a different operating environment and now needs more speed and packaging flexibility. Management said details are still in early design, but the fiscal 2027 savings goal is at least $750 million.

Chief financial officer Kofi Bruce said HMM is meant to fund reinvestment into product and marketing, not just protect margins. That framing makes the productivity push central to the growth plan rather than a separate cost-cutting story.

GIS Delivers a Beat, but GAAP Was DistortedFor the quarter, General Mills reported adjusted EPS of $0.95 and revenue of $4.61 billion. That topped the Zacks Consensus Estimate of $0.82 and $4.6 billion, respectively, with EPS surprise of 15.9% and revenue surprise of 0.1%.

Those adjusted results aligned with management’s own expectations, but GAAP figures were heavily distorted. The company posted a loss per share of $3.74, driven by $1.8 billion in goodwill and brand impairment charges and a roughly $1.0 billion valuation loss tied to the planned sale of the Brazil business.

That split between adjusted and reported results shaped the tone of the call. Executives spent little time defending the quarter itself and much more time arguing that the underlying business, especially pricing, household penetration and base volume, is on firmer footing entering fiscal 2027.

General Mills Leaves a Measured But Assertive ToneThe closing message from management was disciplined rather than upbeat. Harmening said the company is on a path to restore profitable growth, but the near-term setup still includes inflation, lapping the 53rd week and divestiture-related headwinds.

Even so, executives sounded more assertive in Q&A than in the headline numbers. Their stance was that fiscal 2027 improvement depends on better execution, better innovation and better mix, not relief from the consumer environment.

Zacks Signals Remain Cautious on GISGIS carries a Zacks Rank #4 (Sell), alongside a Value Score of A, Growth Score of F, Momentum Score of D and VGM Score of D. Under Zacks’ framework, Style Scores work best as a complement to the Zacks Rank, and stronger combinations are generally Rank #1 (Strong Buy) or #2 (Buy) stocks with A or B style grades. You can see the complete list of today’s Zacks #1 Rank stocks here.

That leaves a mixed signal. The value profile stands out, but Zacks’ own guidance says investors should not buy stocks with a Zacks Rank #4 or #5 (Strong Sell) even if some Style Scores are favorable, and the rank can change as estimate revisions move after the quarter.

© 2015 Getty Images / Getty Images News via Getty Images

The AI gold rush continues in mid-2026, with companies racing to turn flashy models into actual money-making systems. While the market obsesses over token prices and frontier lab drama, a quieter shift is underway. 

Governments and enterprises want AI they control — not rent — especially when national security or trade secrets sit on the line. Palantir Technologies’ (NYSE:PLTR | PLTR Price Prediction) just-announced partnership with Nvidia (NASDAQ:NVDA) taps directly into that demand.

Here is what actually matters here for long-term shareholders.

Real Control in Sovereign Environments The deal integrates Nvidia’s Nemotron open-weight models into Palantir’s Sovereign AI Operating System. Customers in U.S. government agencies and critical infrastructure gain the ability to deploy, customize, and post-train models on their own data — while keeping full ownership of the resulting model weights.

In plain English, this is not another vague AI announcement. Palantir supplies the ontology layer that structures messy data into usable intelligence, plus deployment tools via AIP, Foundry, and Apollo. Nvidia brings the hardware acceleration and open models. Together they create a secure, on-premises or air-gapped stack that closed labs like OpenAI and Anthropic struggle to match on data sovereignty.

Palantir CEO Alex Karp highlighted this exact point during his July 1 CNBC appearance. Enterprises and agencies grow tired of unpredictable token costs and the risk of transferring their “alpha” — competitive advantage — to third parties. Palantir’s approach lets them own the means of production.

Stop renting AI from Big Tech. Palantir and Nvidia just teamed up to give governments and giants complete control—and the financial muscle behind it is staggering. © 24/7 Wall St. Numbers That Tell the Real Story Palantir isn’t pitching this from weakness. The company reported $1.6 billion in Q1 revenue, up 85% year-over-year — its fastest growth since going public. U.S. revenue hit $1.28 billion, more than double the year-ago period, with U.S. commercial up 133% and government up 84%. Management raised full-year revenue guidance to $7.650 billion to $7.662 billion, implying roughly 71% growth, and lifted U.S. commercial guidance to over $3.224 billion — at least 120% growth. 

The Rule of 40 score reached 145%, a mark matched by only a few AI infrastructure names like Nvidia itself. Adjusted free cash flow came in at $925 million in the quarter, or 57% FCF margin, and the balance sheet showed $8 billion in cash and equivalents.

Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

Compare that to the broader picture. While many software peers chase 20% to 30% growth, Palantir delivers triple-digit commercial acceleration in the U.S. The sovereign AI push builds on existing federal momentum and opens doors in regulated commercial sectors that need similar data control.

The Moat Most Analysts Overlook Here’s what receives too little attention: switching costs. Once an agency or critical infrastructure operator builds workflows on Palantir’s ontology, ripping it out becomes painful. Add Nvidia’s performance layer and you get a full-stack solution hard to replicate.

This matters because sovereign AI infrastructure could grow into a $177 billion market by 2035 at a 28% CAGR, according to Precedence Research. Palantir doesn’t need to win every dollar — it only needs to become the default operating layer for the most sensitive workloads.

Granted, the valuation sits at a trailing P/E around 141x. That leaves little room for disappointment if federal contract pacing slows or if international expansion lags. That said, the company generates real cash and shows accelerating momentum that justifies a premium for many growth investors.

Key Takeaway The Palantir-Nvidia deal quietly strengthens Palantir’s position as infrastructure rather than just another AI tool provider. With 85% revenue growth in Q1, guidance raised 71% for the full year, and a platform built for control-hungry customers, the setup favors patient shareholders who focus on execution over daily volatility.

Smart investors will watch upcoming contract announcements and Q2 results for confirmation that this partnership moves from headline to revenue. In the end, the winners in AI won’t just have the best models — they will have the best systems for using them securely at scale. Palantir and Nvidia just made a strong case for why they belong in that group.

Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

Contact [email protected] for any questions or corrections.

Malaysia: TotalEnergies Divests its Minority Non-Operated Interest in Marjoram Gas Field TotalEnergies (Paris:TTE) LSE:TTE NYSE:TTE announces the divestment to INPEX of its 85% interest in Block 2E offshore Malaysia, representing a net interest of 8.5% in the Marjoram gas field currently under development, for a consideration of USD 350 million.

Through this transaction, TotalEnergies crystallizes the full value of this minority interest in a non-operated gas project, to focus on its operated portfolio and strategic growth opportunities in Malaysia.

“This agreement is fully aligned with our strategy of actively managing our portfolio and prioritizing material positions to support our ambition to develop low-cost, low-emission projects. With Jerun field now on stream and a large portfolio of opportunities, Malaysia is a strategic platform for TotalEnergies’ low-cost, low-emission growth strategy, serving both the country and the wider Southeast Asia region,” said Nicolas Terraz, President Exploration & Production at TotalEnergies.

***

About TotalEnergies in Malaysia
TotalEnergies has been present in Malaysia since 1985 and has maintained a long-standing partnership with the national oil company PETRONAS. Following the acquisition of SapuraOMV Upstream, TotalEnergies became the country’s third-largest gas producer.
The Group employs around 300 people in Malaysia and holds operated and non-operated interests in 17 offshore blocks off the coast of Sarawak and Sabah.
Through its subsidiary TotalEnergies Marketing Malaysia, TotalEnergies also markets petroleum products. In 2023, the Group signed an agreement with PETRONAS and Mitsui to develop a CO₂ storage project in Southeast Asia and to assess several potential sites in the Malay Basin.
On the 2nd of April 2026 TotalEnergies and Masdar announced the creation of a $2.2 billion joint venture to accelerate the growth of renewable energy in Asia and particularly in Malaysia.

About TotalEnergies
TotalEnergies is a global integrated multi-energy company that produces and markets energies: oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables and electricity. Our more than 100,000 employees are committed to providing as many people as possible with energy that is more affordable, more available and more sustainable. Present in around 120 countries, TotalEnergies places sustainable development at the heart of its strategy, its projects and its operations.

@TotalEnergies TotalEnergies TotalEnergies TotalEnergies

Cautionary Note
The terms “TotalEnergies”, “TotalEnergies company” or “Company” in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words “we”, “us” and “our” may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies’ financial results or activities is provided in the most recent Universal Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC).

View source version on businesswire.com: https://www.businesswire.com/news/home/20260630556148/en/

Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.

Click for the complete disclosure

, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and global markets, today announced that its board of directors has authorized a new share repurchase program, under which the Company may repurchase up to 10% of total issued and outstanding Ordinary Shares and/or American depositary shares ("ADSs") for up to US$20 million over the next 12 months, effective as of the date hereof.

The Company's proposed repurchases may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, including through Rule 10b5-1 trading plans, depending on market conditions and in accordance with applicable laws, rules and regulations. The timing and amount of repurchases, if any, will be subject to market conditions, trading price, trading volume and other factors. The Company's board of directors will review the share repurchase program periodically and may authorize adjustments to its terms and size. The Company expects to fund the repurchases from its existing cash balance.

About Yiren Digital

Yiren Digital Ltd. is a leading fintech company specializing in digital consumer lending, insurance, and financial technology innovation across China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. Following the regulatory filing of its in-house developed Large Language Model Zhiyu, and the significant enhancement of its MagiCube Agent platform, Yiren Digital is establishing a new growth engine to accelerate its evolution into an AI-native, multi-industry operating platform extending beyond traditional financial services. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "aim," "anticipate," "believe," "estimate," "expect," "hope," "going forward," "intend," "ought to," "plan," "project," "potential," "seek," "may," "might," "can," "could," "will," "would," "shall," "should," "is likely to" and the negative form of these words and other similar expressions. This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions. Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of the Company, and which could cause actual results to differ materially from those expressed or implied in such statements. Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital Ltd.

July 02, 2026 06:00 ET  | Source: The Ensign Group, Inc.

SAN JUAN CAPISTRANO, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of (i) “Las Ventanas de Socorro”, a 126-bed skilled nursing facility located in Socorro, Texas, and (ii) “Los Arcos del Norte Care Center”, a 124-bed skilled nursing facility located in El Paso, Texas. The real estate was acquired by subsidiaries of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company, and the facilities are operated by Ensign-affiliated tenants. The acquisition was effective as of July 1, 2026.

“We are excited to continue our incredible year in Texas with the acquisition of these excellent facilities”, said Barry Port, Ensign's Chief Executive Officer. “We are always looking to expand our presence in Texas, and these facilities are tremendous adds to our operations and Standard Bearer’s real estate footprint”, he added.

Andy Ashton, President of Keystone Care LLC, Ensign’s Texas-based subsidiary, added, “Both facilities have fantastic teams of caregivers, and we are so excited to begin serving our residents and their families in the El Paso area.”

These acquisitions were effective July 1, 2026, and bring Ensign's growing portfolio to 398 healthcare operations, which includes 48 senior living operations, across 17 states. Ensign subsidiaries, including Standard Bearer, own 183 real estate assets. Mr. Port reaffirmed that Ensign is actively seeking opportunities to acquire real estate and to lease both well-performing and struggling skilled nursing, senior living and other healthcare related businesses throughout the United States.

About Ensign™

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 398 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.

Contact Information

The Ensign Group, Inc., (949) 487-9500, [email protected]

SOURCE: The Ensign Group, Inc.

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today it has acquired Thymmune Therapeutics, Inc. (Thymmune), a privately held, preclinical stage biotechnology company developing scalable, regenerative thymic cell therapies for the potential treatment of post-transplant organ tolerance, immunodeficiencies, and autoimmune diseases.

The thymus is a critical organ for the development and proper function of key parts of the immune system, including training T-cells, which are essential for fighting infections and other diseases. Thymmune has a proprietary process for converting human-induced pluripotent stem cells (iPSC) into thymic cells, which — once inside the body — mature into cell types that can restore healthy T-cell function.

Thymmune’s lead candidate, THY-100, is in preclinical development for congenital athymia, an ultra-rare and life-threatening condition in which infants are born without a functional thymus. Animal studies have shown that treatment with THY-100 results in the in vivo formation of a neo-thymus that is capable of facilitating T-cell development. The clinical proof of concept and further development of THY-100 has the potential to broaden thymic regenerative medicine approaches for transplant tolerance, serious immune-mediated diseases, and enhanced longevity for older adults with diminished T-cell function.

“Thymmune’s platform complements United Therapeutics’ broader mission to expand the supply of transplantable organs, building on our UThymoKidney™ clinical development program and our growing strength in immunomodulatory therapeutics,” said Martine Rothblatt, Ph.D., Chairperson and Chief Executive Officer of United Therapeutics. “By restoring or modulating T-cell receptor diversity, Thymmune’s technology could make fundamental contributions to human health care and potentially resolve the root causes of dozens of life-threatening diseases.”

“Thymmune was founded to harness the biology of the thymus to restore immune function for patients with serious immune-mediated diseases,” said Stan Wang, M.D., Ph.D., Chief Executive Officer and Founder of Thymmune Therapeutics. “United Therapeutics shares our conviction that regenerative medicine can transform the lives of patients, and we believe its leadership in organ alternatives and cell-based technologies makes it the ideal partner to advance our platform toward broad clinical impact.”

Under the terms of the agreement, United Therapeutics acquired Thymmune for $140 million in cash, subject to certain post-closing adjustments, plus potential earn-out payments to former Thymmune equityholders of up to $160 million based upon the achievement of certain clinical and regulatory milestones by the end of 2031.

About United Therapeutics

Founded by CEO Martine Rothblatt to discover a cure for her daughter's life-threatening rare disease, pulmonary arterial hypertension, United Therapeutics transforms the treatment of rare diseases and pioneers alternatives to expand the supply of transplantable organs. From our innovative therapies to our groundbreaking manufactured organs, we are bold and unconventional. We move quickly from scientific theory to practical technologies that can save lives. As a public benefit corporation, even our legal structure reflects our commitments. We serve patients, act with integrity, create long-term shareholder value, and operate with sustainable practices that protect the future we are working to build. Visit us at www.unither.com and follow us on LinkedIn, Facebook, and Instagram.

Forward-Looking Statements

Statements included in this press release that are not historical in nature are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, statements regarding our plans to develop THY-100 and other products based on Thymmune’s technology, including the potential to broaden thymic regenerative medicine approaches for transplant tolerance, serious immune-mediated diseases, and enhanced longevity for older adults with diminished T-cell function, the potential for Thymmune’s technology to support our organ manufacturing programs, the potential for Thymmune’s technology to make fundamental contributions to human health care and potentially resolve the root causes of dozens of life-threatening diseases, the potential earn-out payments to the former Thymmune stockholders, our goals of expanding the supply of transplantable organs, developing practical technologies that can save lives, creating long-term shareholder value, and operating with sustainable practices. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual results to differ materially from anticipated results. Consequently, such forward-looking statements are qualified by the cautionary statements, cautionary language, and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of July 2, 2026, and assume no obligation to update or revise the information contained in this press release whether because of new information, future events, or any other reason.

UTHYMOKIDNEY is a trademark of United Therapeutics Corporation.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Payoneer (NASDAQ: PAYO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Nuvei.

Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

Payoneer stockholders will receive $7.40 per share in cash, representing a total transaction equity value of approximately $2.75 billion. Payoneer insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Payoneer by imposing a significant penalty if Payoneer accepts a competing bid. We are investigating the conduct of the Payoneer board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- The Catastrophe and Risk Solutions group at Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, estimates economic losses from the June 24, 2026 earthquakes in Venezuela will likely exceed USD 10 billion. Verisk notes a higher degree of uncertainty than usual in estimating the insured share of industry losses because of Venezuela's macroeconomic conditions, elevated inflation, low insurance penetration, and sanctions-related market complexities.

Earthquake Sequence and Impacts

On June 24, Venezuela was struck by a rare earthquake doublet near Yumare-Morón in Yaracuy state, approximately 100 miles west of Caracas. A magnitude 7.2 foreshock was followed just 39 seconds later by a magnitude 7.5 mainshock, making it the strongest earthquake to impact Venezuela since 1900. The shallow strike-slip rupture occurred along the San Sebastián fault system within the tectonically active boundary zone between the Caribbean and South American plates and was subsequently followed by more than 430 recorded aftershocks.

Damage was most severe in the Caracas metropolitan region and the coastal state of La Guaira, where an estimated 1,400 buildings were destroyed. Significant destruction was also reported across Aragua, Carabobo, and Yaracuy states. Communities including Puerto Cabello, Catia La Mar, Maiquetía, San Felipe, Los Teques, Petare, Valencia, and Baruta experienced severe shaking, according to U.S. Geological Survey intensity estimates.

Modeling Information 

Because of Venezuela's economic environment, Verisk notes greater uncertainty than is typical for an industry loss estimate. Factors contributing to this uncertainty include assumptions regarding earthquake insurance take-up rates, ongoing inflationary pressures, and the challenges associated with accurately valuing insured assets in a rapidly changing economic environment.

The modeled insured loss estimates do not include losses resulting from fire-following, landslides, sprinkler leakage, loss adjustment expenses, damage to uninsured properties or infrastructure, extra-contractual obligations, hazardous waste cleanup, vandalism, or civil commotion, whether directly or indirectly caused by the event. The estimates also exclude losses associated with civil engineering (railway) risks, marine cargo and marine hull risks, aviation risks, transit warehouse risks, personal accident risks, and other non-modeled sources of loss.

Building Stock and Earthquake Vulnerability

Today, the majority of residential buildings in Venezuela's urban areas are constructed of masonry, including reinforced masonry, confined masonry, and unreinforced masonry structures. Reinforced concrete is the predominant construction type in mid- and high-rise residential buildings, particularly in major urban centers such as Caracas.

Although modern engineering standards exist, seismic performance varies significantly due to local construction practices, material quality, and enforcement of building codes.

Insurance Market in Venezuela

Venezuela's insurance and reinsurance sector remains relatively small and highly concentrated compared to many global markets. The industry continues to operate under challenging macroeconomic conditions characterized by elevated inflation, currency depreciation, regulatory complexity, and limited market capacity.

These conditions create additional uncertainty when estimating insured losses following a catastrophe. Variations in earthquake insurance penetration, coverage levels, and insured property values can materially influence the ultimate insured share of economic losses resulting from the earthquake sequence.

About Verisk
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, catastrophic events, sustainability and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses.. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work. For more, visit Verisk.com and the Verisk Newsroom.

Exclusive

By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Paramount Skydance CEO David Ellison has leaned into technology since taking the helm. Ian Gavan/Getty Images for Paramount Pictures; Illustration by Cheng Xin/Getty Images Paramount Skydance has revamped another key tech team as CEO David Ellison's digital transformation takes shape.

Paramount's ad product and tech teams are joining forces, becoming the latest units to get a makeover. Earlier this year, Ellison combined streaming engineering groups and reassigned some staffers who'd helped merge the tech platforms of Paramount+ and free streamer Pluto TV.

Ad product and tech employees learned about the new structure and leaders in a late-June memo from Hugh Williams, a former Google tech exec who joined Paramount this spring as an EVP.

Merging the ad product and tech groups will help create "the modern, unified product and technology organization we set out to build," Williams said in the memo, which was obtained by Business Insider.

Ellison is set on modernizing Paramount, a 114-year-old Hollywood powerhouse that hasn't been known for its tech prowess. He's hoping to narrow the gap with Netflix, both by "prioritizing investments in advanced technology" and by buying Warner Bros. Discovery.

Paramount has made strides in streaming tech by adding a short-form video feed and plans to add interactive features, such as a shopping tool and sports stats. The company is also eyeing video podcasts to drive engagement.

Paramount's rearranged ad product and tech group has five parts, and each unit's leader will report directly to Williams, the EVP said.

Staffers on these teams should prepare for "movement between the groups soon to align with the new team structure," Williams added.

Todd Bender, currently Paramount's EVP of Advertising Platforms, will take on a new role as EVP of Integration, Williams said. Bender will support Williams and product chief Dane Glasgow "in complex integration planning work" with the changes, Williams said in the memo.

Here's a breakdown of Paramount ad product and tech's new structure and leadership team:Product Management (PM)Led by four executives:

Charlie Goodman: SVP, Decisioning & Ad Formats PMMatthew Jacobs: Senior Director, Reporting, Measurement, and Attribution PMGeorge Powell: VP, Ad Platforms & Systems PMMichele Stone: SVP, Revenue Enablement PMDescription: "Accountable for why we do work and what work we do, organized around the full 'pitch to pay' lifecycle of advertising across every screen. This spans how clients and our sales teams plan and transact with us; how we decide, deliver, operate, and shape the ad experience; the shared platforms and infrastructure the organization runs on; and how we measure outcomes and turn delivered value into revenue."EngineeringLed by Rich Orme: EVP, Engineering

Background: Orme joined Paramount in June after working in tech for close to three decades. He most recently started and ran AI advisory firm Leif Partners and previously worked at tech investment firm Silver Lake.Description: "Accountable for how and when we build software. Once the PM team decides what to build, Engineering owns the architecture, design, build, and delivery dates. Almost all of our engineers will report into this new organization."DataLed by TBD

Williams said that Paramount plans to hire an EVP of Data to head up its data science and analytics efforts.Description: "Accountable for how and when we build our data solutions, spanning analytics and data science. Analytics owns the insights, reporting, dashboards, experimentation, and ensuring our data is relevant, reliable, and reusable. They will answer the hard and interesting data questions about Ads. Data science owns the models and algorithms that power our products. Data partners closely with Engineering and is a key partner across Product Management."Advertising SolutionsLed by Dayna Wasilefski: VP, Advertising Solutions

Background: Wasilefski is a longtime Paramount executive stepping in for Paul Mahood, the ad sales product and tech SVP who's leaving the company at the end of July after more than two decades.Description: "Owns the significant vendor solutions that run our customer and linear businesses, including our CRM and all Salesforce instances, linear systems, and the technology behind local, sports, and our other non-streaming businesses. We will continue to deliver these with the availability and continuity the business depends on. This team owns the how and the when for customizing and operating those solutions."Field CTOLed by Travis Scoles: EVP, Field CTODescription: "A small, senior, client-facing team focused on direct relationships with our ad sales teams and advertisers. This team will build small, high-value custom solutions, representing our product and technology strategy to clients and partners, and feeding market intelligence back into the organization. Their work is deliberately one-off: anything that becomes durable is handed back to the broader organization to own and prioritize. The team will also represent Ads Product and Tech in client forums and evangelize Paramount as leaders in the Ads space."Paramount has a new-look leadership teamEllison's Paramount has had plenty of leadership changes this year.

Besides bringing on Williams, the company also landed former Google AI language product exec Barak Turovsky in May as its head of consumer AI. And in March, Paramount hired Danielle Carney from Amazon to oversee its US ad sales team.

Meanwhile, tech chief Phil Wiser left the company in late May. A few months earlier, agency partnerships EVP Chris Simon stepped down, and streaming product and tech chief Vibol Hou also left.

Read next

James Faris You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Media Exclusive

By Reuters

July 2, 20267:42 AM UTCUpdated 1 hour ago

Tesla Model 3 vehicles are shown for sale at a Tesla facility in Long Beach, California, U.S., May 22, 2023. REUTERS/Mike Blake Purchase Licensing Rights, opens new tab

CompaniesJuly 2 (Reuters) - The U.S. National Highway Traffic Safety Administration (NHTSA) on Thursday said it ​had closed its 2022 preliminary evaluation ‌into 695,000 Tesla (TSLA.O), opens new tab vehicles over unexpected deceleration, citing low demonstrated hazard to drivers and a ​substantial drop in incidents.

Here are a ​few details:

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

The investigation covered Model 3 and ⁠Model Y vehicles.

NHTSA said that Tesla ​had released software updates in early ​2022 to target unexpected deceleration.

Incident reports declined to 45 in 2024, 19 in 2025, and ​three since the start of 2026, ​according to the auto safety regulator. There were ‌300 ⁠such reports when the investigation was opened.

The regulator said the reported conditions did not alter the vehicle’s lateral positioning ​in their ​lanes and ⁠did not cause significant loss in distance between the subject ​and following vehicle to lead ​to ⁠a collision.

Last week, NHTSA had separately closed an expanded probe covering an estimated 376,241 ⁠Model ​3 and Model Y ​vehicles over loss of steering control.

Reporting by Disha ​Mishra in Bengaluru; Editing by Nivedita Bhattacharjee

Our Standards: The Thomson Reuters Trust Principles., opens new tab

HomeStock IdeasLong IdeasTech 

SummaryMicrosoft's RPO surged 99% year over year to $627 billion, with approximately $157 billion expected to convert into revenue within 12 months.AI monetization extends beyond inference, driving strong growth across Cosmos DB, OneLake, Azure infrastructure, storage, compliance, and enterprise data services.AI ARR reached $37 billion, up 123% year over year, while Azure is guided to deliver approximately 40% constant-currency growth next quarter.Microsoft's multi-model AI strategy and Maia/Cobalt silicon should reduce inference costs, supporting long-term margin expansion despite elevated infrastructure investments.Risks include a projected $190 billion FY26 CapEx program, declining cloud gross margins, regulatory scrutiny, and increasing competition following OpenAI's reduced exclusivity. tupungato/iStock Editorial via Getty Images

Investment Thesis Microsoft's (MSFT) narrative has changed dramatically over the last few quarters. The question now is not whether Microsoft can monetize AI but how much monetization has been locked in already. MSFT is

17.13K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in MSFT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.